Scientists at the University of California, San Francisco (UCSF), have discovered how to target a class of molecular switches called GTPases that are involved in a myriad of diseases—from Parkinson’s ...
This article and associated images are based on a poster originally authored by Oliver Carney, Louis Hodgson, and Carl Peters, and presented at ELRIG Drug Discovery 2025 in affiliation with BMG ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results